Regeneron(REGN) - 2025 Q3 - Earnings Call Transcript

Regeneron Pharmaceuticals (NasdaqGS:REGN) Q3 2025 Earnings Call October 28, 2025 08:30 AM ET Company ParticipantsGeorge Yancopoulos - President and CSOChris Fenimore - CFOMarion McCourt - EVP of CommercialLeonard Schleifer - President and CEORyan Crowe - SVP of Investor RelationsConference Call ParticipantsSimon Goodwin - AnalystJeffrey Meacham - AnalystTerrence Flynn - AnalystBrian Abrahams - AnalystAkash Tewari - AnalystSalveen Richter - AnalystTyler Van Buren - AnalystAlexandria Hammond - AnalystCory Kas ...